It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
[...]there is an urgent need to investigate the safety and humoral immune responses of inactivated vaccines in cancer patients. [...]although the overall frequency of RBD+ MBCs was higher in cancer patients, immune memory was impaired. [...]an assessment of the third “booster” dose and immunity against variants of concerns was not performed, which hindered further analysis, such as the immunity against Delta or Omicrons variants after inactivated vaccination. [...]only patients with solid tumors were included in our study, while patients with hematologic malignancies were excluded, which might have impacted the results, given the higher immunosuppressive status of the latter [ 10].
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
2 Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
3 Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
4 Department of Thoracic and Cardiovascular Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
5 Department of Breast and Thyroid Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
6 Department of Gynaecology and Obstetrics, Reproductive Medicine Center, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China




